"Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia"
written by Eric L. Matteson, Tim Bongartz, Jay H. Ryu, Cynthia S. Crowson, Thomas E. Hartman, Paul F. Dellaripa,
published by Open Journal of Rheumatology and Autoimmune Diseases, Vol.2 No.3, 2012
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Is there a Role for Biologic Agents in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease?
Revista Americana de Medicina Respiratoria
[2] Biologic treatments in interstitial lung diseases
2019
[3] Rituximab in connective tissue disease–associated interstitial lung disease
2019
[4] Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)
2019
[5] Mechanisms of lung disease development in rheumatoid arthritis
2019
[6] Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease
2019
[7] Thoracic Manifestations of Rheumatoid Arthritis
2019
[8] Análisis de las características clínico-analíticas de pacientes con artritis reumatoide y enfermedad pulmonar intersticial: casos y controles
2019
[9] Interstitial lung disease in rheumatoid arthritis remains a challenge for clinicians
2019
[10] Rethinking articular cartilage regeneration based on a 250-year-old statement
2019
[11] Management of the Rheumatoid Arthritis Patient with Interstitial Lung Disease
Lung Disease in Rheumatoid Arthritis, 2018
[12] Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review
Natural Product Research, 2018
[13] ScienceCentral Journals
2017
[14] Recent advances in connective tissue disease related interstitial lung disease
Journal of Land Use Science, 2017
[15] Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years' experience at a single centre
Rheumatology, 2017
[16] Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis
Rheumatology and Therapy, 2017
[17] Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic
2017
[18] Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view
The Korean journal of internal medicine, 2017
[19] «Общероссийский регистр пациентов с системным ювенильным идиопатическим артритом» -эффективный инструмент мониторинга заболевания и медицинской помощи
2016
[20] Connective tissue disease-related interstitial lung disease
Best Practice & Research Clinical Rheumatology, 2016
[21] Drug-induced lung disease in rheumatoid arthritis
2016
[22] Management of connective tissue diseases associated interstitial lung disease: a review of the published literature
Current opinion in rheumatology, 2016
[23] Rituximab for the treatment of connective tissue disease-associated interstitial lung disease
Sarcoidosis vasculitis and diffuse lung disease, 2016
[24] Connective Tissue Disease-Associated Interstitial Lung Diseases: Unresolved Issues
Seminars in respiratory and critical care medicine, 2016
[25] The effect of disease modifying drugs on the lung in patients with rheumatoid arthritis
The Southwest Respiratory and Critical Care Chronicles, 2016
[26] ¿ Hay un rol para los agentes biológicos en el tratamiento de la patología pulmonar intersticial asociada a enfermedades del tejido conectivo?
Revista americana de medicina respiratoria, 2016
[27] Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease
Society & Natural Resources, 2016
[28] Academic Content and Language Evaluation of This Article
2015
[29] Rheumatoid Arthritis-associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared mechanistic and phenotypic traits suggest overlapping …
Revista de Investigación Clínica, 2015
[30] Management of Connective Tissue Disease–associated Interstitial Lung Disease
Rheumatic Disease Clinics of North America, 2015
[31] Assessment and management of connective tissue disease-associated interstitial lung disease
Sarcoidosis vasculitis and diffuse lung disease, 2015
[32] Efficacy and safety of rituximab in connective tissue disease related interstitial lung disease
Sarcoidosis vasculitis and diffuse lung disease, 2015
[33] Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis
Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 2015
[34] The Lung Disease of Rheumatoid Arthritis
Current Respiratory Medicine Reviews, 2015
[35] Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review
Therapeutic advances in musculoskeletal disease, 2015
[36] Sobre el tratamiento de la enfermedad pulmonar intersticial en artritis reumatoide
El Residente, 2015
[37] Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis: shared mechanistic and phenotypic traits suggest overlapping disease …
2015
[38] Romatoid artrit ile ilişkili interstisyel akciğer hastalığı.
2015
[39] Romatoid artrit ile iliflkili interstisyel akci¤ er hastal›¤›
2015
[40] Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis: shared mechanistic and phenotypic traits suggest overlapping …
2015
[41] The safety of biologic therapies in RA-associated interstitial lung disease
Nature Reviews Rheumatology, 2014
[42] Targeting B Lymphocytes in Progressive Fibrosing Mediastinitis
American journal of respiratory and critical care medicine, 2014
[43] Rheumatoid Arthritis and Lung Disease: From Mechanisms to a Practical Approach
Seminars in respiratory and critical care medicine. Vol. 35. No. 02. Thieme Medical Publishers, 2014
[44] Interstitial lung disease in rheumatoid arthritis: Current concepts in pathogenesis, diagnosis and therapeutics
2014
[45] Lung disease in rheumatoid arthritis. Challenges and opportunities
Shortness of breath, 2013
[46] Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis
Expert review of clinical immunology, 2013
[47] Investigation of clinical manifestations in korean colorectal cancer patients
Annals of Coloproctology, 2013
[48] Interstitial lung disease in rheumatoid arthritis
2012
[49] Safe use of antirheumatic agents in patients with comorbidities
Rheumatic Disease Clinics of North America, 2012